BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35577277)

  • 21. Preparation and characterization of anti-GP73 monoclonal antibodies and development of double-antibody sandwich ELISA.
    Li QW; Chen HB; Li ZY; Shen P; Qu LL; Gong LL; Xu HP; Pang L; Si J
    Asian Pac J Cancer Prev; 2015; 16(5):2043-9. PubMed ID: 25773808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation.
    Sai WL; Yao M; Shen SJ; Zheng WJ; Sun JY; Wu MN; Wang L; Yao DF
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):449-454. PubMed ID: 32171652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Golgi Protein 73 (GP73) as a Potential Biomarkers for Hepatocellular Carcinoma.
    Shaker MK; Attia FM; Hassan AA; Shedid MM; Aboelmagd MA; Faisal AS
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
    Ibrahim GH; Mahmoud MA; Aly NM
    Mol Biol Rep; 2013 Dec; 40(12):7069-75. PubMed ID: 24186850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical application of serum Golgi protein 73 in patients with chronic liver diseases].
    Liu YN; Yao MJ; Zheng SJ; Chen XM; Liu XY; Hu P; Ou QS; Dou XG; Chen HS; Duan ZP; Hou JL; Nan YM; Gao ZL; Xu XY; Zhuang H; Lu FM
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):4-8. PubMed ID: 35152664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
    Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
    PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma].
    Bao YX; Yang Y; Zhao HR; Mao R; Xiao L; Zhang YF; Aisiker T; Wen H
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):505-8. PubMed ID: 24257301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
    Zhao Y; Li Y; Hu B; He X; Huang J; Zhan M; Lu L
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):390-2. PubMed ID: 24746091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
    Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential value of serum GP73 in the ancillary diagnosis and grading of liver cirrhosis.
    Hui-Ling C; Kang-Ming H; Yu Z; Yin-Han D; Huang D; Shu-Ping X; Hong-Bin C
    Scand J Clin Lab Invest; 2023 Apr; 83(2):95-102. PubMed ID: 36786815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma.
    Shi Y; Chen J; Li L; Sun Z; Zen L; Xu S; Zhang Y; Zhang L
    Technol Cancer Res Treat; 2011 Jun; 10(3):287-94. PubMed ID: 21517136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glypican-3, Vascular Endothelial Growth Factor and Golgi Protein-73 for Differentiation between Liver Cirrhosis and Hepatocellular Carcinoma.
    Mamdouh S; Soliman A; Khorshed F; Saber M
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):497-507. PubMed ID: 36853298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival.
    Sun Y; Yang H; Mao Y; Xu H; Zhang J; Li G; Lu X; Sang X; Zhao H; Zhong S; Huang J; Zhang H
    J Gastroenterol Hepatol; 2011 Jul; 26(7):1207-12. PubMed ID: 21443671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.
    Cao Z; Li Z; Wang Y; Liu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Wang H; Cai W; Liu L; Zhu C; Bao S; Xie Q
    J Viral Hepat; 2017 Nov; 24 Suppl 1():57-65. PubMed ID: 29082644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
    Mao Y; Yang H; Xu H; Lu X; Sang X; Du S; Zhao H; Chen W; Xu Y; Chi T; Yang Z; Cai J; Li H; Chen J; Zhong S; Mohanti SR; Lopez-Soler R; Millis JM; Huang J; Zhang H
    Gut; 2010 Dec; 59(12):1687-93. PubMed ID: 20876776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
    Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
    Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Value of GPC3 and GP73 in Clinical Diagnosis of Hepatocellular Carcinoma.
    Jing JS; Ye W; Jiang YK; Ma J; Zhu MQ; Ma JM; Zhou H; Yu LQ; Yang YF; Wang SC
    Clin Lab; 2017 Nov; 63(11):1903-1909. PubMed ID: 29226636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.
    Yao S; Zhang J; Chen H; Sheng Y; Zhang X; Liu Z; Zhang C
    J Histochem Cytochem; 2013 Sep; 61(9):639-48. PubMed ID: 23686365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73.
    Liang H; Block TM; Wang M; Nefsky B; Long R; Hafner J; Mehta AS; Marrero J; Gish R; Norton PA
    Cancer Biomark; 2012; 11(4):161-71. PubMed ID: 23144154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.